Biofrontera Inc. (BFRI)
(Delayed Data from NSDQ)
$0.95 USD
-0.07 (-6.86%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $0.92 -0.03 (-3.16%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Biofrontera Inc. has a market cap of $10.34M, which represents its share price of $1.02 multiplied by its outstanding shares number of 10.14M. As a small-cap company, BFRI's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BFRI 0.95 -0.07(-6.86%)
Will BFRI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BFRI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BFRI
Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
BFRI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates
Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates
Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates
Other News for BFRI
Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025 | BFRI ...
Biofrontera Inc. (BFRI) Announces Plan to Offer 13.6 Million Shares | BFRI Stock News
Biofrontera files to sell 13.6M shares of common stock by selling shareholders
Biofrontera Inc. files to sell 13.6M shares of common stock for holders
Biofrontera restructures relationship with Biofrontera AG, backed by $11M investment